Insulin aspart has a shorter duration of action than human insulin over a wide dose-range. Diabetes Obes Metab. 2013;15:77- 83.Nosek L, Roggen K, Heinemann L, Gottschalk C, Kaiser M, Arnolds S, et al. Insulin aspart has a shorter duration of action than human insulin over a wide ...
Insulin aspart has a shorter duration of action than human insulin over a wide dose-range AimsRegular human insulin (RHI) at high doses shows prolongation of its duration of action potentially leading to late postprandial hypoglycaemia. This stu... L Nosek,K Roggen,L Heinemann,... - 《...
InsulinPreparation Onset of Action Peak Action Duration of Action Rapid-acting Lispro, aspart, glulisine† 5–15 minutes 45–75 minutes 3–5 hours Inhaled regular < 15 minutes 50 minutes 2–3 hours Short-acting Regular† 30–60 minutes ...
Comparison of insulin detemir and insulin glargine in a basal—bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes... value 鈮 11.0% at screening. Patients were randomized in a 2:1 ratio to receive either detemir or glargine for 52 weeks. The basal...
Influence of BMI, age and duration of diabetes mellitus on glycaemic control with twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart (JDDM 18): retrospective reanal- ysis of a 6 month, randomized, open-label, multicentre trial in Japan. Clin ...
Influence of BMI, age and duration of diabetes mellitus on glycaemic control with twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart (JDDM 18): retrospective reanalysis of a 6-month, randomized, open-label, multicentre trial in Japan. Clin Drug...
A1chieve was a 24-week, non-interventional study evaluating safety and effectiveness of an insulin analog (detemir, aspart, biphasic insulin aspart 30) in 66 726 people with type 2 diabetes in 28 countries. The present analysis addressed safety and effectiveness in insulin-na茂ve groups with ...